Updating the 2003 European regulatory requirements for registering disease-modifying drugs to be used in the treatment of rheumatoid arthritis.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Smolen, JS; Boers, M; Abadie, EC; Breedveld, FC; Emery, P; Bardin, T; Goel, N; Ethgen, DJ; Avouac, BP; Durez, P; Flamion, B; Laslop, A; Miossec, P; Reiter, S; Reginster, J-Y; Task Force of the Group for the Respect of Ethics and Excellence in Science,

Published Date

  • October 2011

Published In

Volume / Issue

  • 50 / 10

Start / End Page

  • 1732 - 1736

PubMed ID

  • 21242246

Pubmed Central ID

  • 21242246

Electronic International Standard Serial Number (EISSN)

  • 1462-0332

Digital Object Identifier (DOI)

  • 10.1093/rheumatology/keq413

Language

  • eng

Conference Location

  • England